Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials.

The effectiveness of the Mediterranean diet (MD) in non-alcoholic fatty liver disease (NAFLD) subjects has been evaluated in several randomized controlled trials (RCTs). This systematic review and meta-analysis aimed to evaluate the overall effects of MD intervention in a cohort of NAFLD patients ta...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrients Vol. 15; no. 10; pp. 2250 - 2268
Autores principales: Del Bo', Cristian, Perna, Simone, Allehdan, Sabika, Rafique, Ayesha, Saad, Sara, AlGhareeb, Fahad, Rondanelli, Mariangela, Tayyem, Reema F., Marino, Mirko, Martini, Daniela, Riso, Patrizia
Formato: meta analysis research systematic review tables/charts Journal Article
Publicado: MDPI May2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163988934&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 163988934
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726643
        B0TT
      jtl: Nutrients
      issn: 20726643
      maglogo: N
    pubinfo:
      dt: May2023
      vid: 15
      iid: 10
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        163988934
        163988934
        163988934
        10.3390/nu15102250
        163988934
      ppf: 2250
      ppct: 18
      formats:
      tig:
        atl: Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials.
      aug:
        au:
          Del Bo', Cristian
          Perna, Simone
          Allehdan, Sabika
          Rafique, Ayesha
          Saad, Sara
          AlGhareeb, Fahad
          Rondanelli, Mariangela
          Tayyem, Reema F.
          Marino, Mirko
          Martini, Daniela
          Riso, Patrizia
        affil: Department of Food, Environmental and Nutritional Sciences (DeFENS), Division of Human Nutrition, Università degli Studi di Milano, 20133 Milano, Italy
      sug:
        subj:
          Mediterranean Diet
          Lipids Metabolism
          Obesity
          Liver Physiology
          Enzymes
          Nonalcoholic Fatty Liver Disease Diet Therapy
          Treatment Outcomes Evaluation
          Human
          Systematic Review
          Meta Analysis
          Fibrosis Prevention and Control
          Adipose Tissue
          PubMed
          Biological Markers
          Descriptive Statistics
      ab: The effectiveness of the Mediterranean diet (MD) in non-alcoholic fatty liver disease (NAFLD) subjects has been evaluated in several randomized controlled trials (RCTs). This systematic review and meta-analysis aimed to evaluate the overall effects of MD intervention in a cohort of NAFLD patients targeting specific markers such as central obesity, lipid profile, liver enzymes and fibrosis, and intrahepatic fat (IHF). Google Scholar, PubMed, and Scopus were explored to collect relevant studies from the last 10 years. RCTs with NAFLD subjects were included in this systematic review with a mean intervention duration from 6 weeks to 1 year, and different intervention strategies, mainly including energy restriction MD (normal or low glycaemic index), low-fat MD with increased monounsaturated and polyunsaturated fatty acids, and increased exercise expenditure. The outcomes measured in this meta-analysis were gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), total cholesterol (TC), waist circumference (WC), and liver fibrosis. Ten randomized controlled trials, which involved a total of 737 adults with NAFLD, were included. According to the results, the MD seems to decrease the liver stiffness (kPa) by –0.42 (CI95% –0.92, 0.09) (p = 0.10) and significantly reduce the TC by –0.46 mg/dl (CI95% –0.55, −0.38) (p = 0.001), while no significant findings were documented for liver enzymes and WC among patients with NAFLD. In conclusion, the MD might reduce indirect and direct outcomes linked with NAFLD severity, such as TC, liver fibrosis, and WC, although it is important to consider the variations across trials. Further RCTs are necessary to corroborate the findings obtained and provide further evidence on the role of the MD in the modulation of other disorders related to NAFLD.
      pubtype: Academic Journal
      doctype:
        meta analysis
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N